• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NAFLD, MAFLD and DAFLD.

作者信息

Mantovani Alessandro, Dalbeni Andrea

机构信息

Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Section of General Medicine, Hypertension and Liver Unit, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

出版信息

Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2.

DOI:10.1016/j.dld.2020.09.013
PMID:33012657
Abstract
摘要

相似文献

1
NAFLD, MAFLD and DAFLD.非酒精性脂肪性肝病、代谢相关脂肪性肝病和糖尿病性脂肪性肝病。
Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2.
2
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
3
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).随着我们从单纯性非酒精性脂肪性肝病（NAFLD）时代过渡到代谢相关脂肪性肝病（DAFLD）时代，NAFLD 取得了进展。
Metabolism. 2020 Oct;111S:154318. doi: 10.1016/j.metabol.2020.154318. Epub 2020 Jul 21.
4
MAFLD: How is it different from NAFLD?MAFLD：与非酒精性脂肪性肝病（NAFLD）有何不同？
Clin Mol Hepatol. 2023 Feb;29(Suppl):S17-S31. doi: 10.3350/cmh.2022.0367. Epub 2022 Nov 29.
5
MAFLD vs NAFLD: Where are we?代谢相关脂肪性肝病与非酒精性脂肪性肝病：我们目前处于什么阶段？
Dig Liver Dis. 2021 Oct;53(10):1368-1372. doi: 10.1016/j.dld.2021.05.014. Epub 2021 Jun 7.
6
[NASH: new terminology and what else is new in 2020].[非酒精性脂肪性肝炎：新术语及2020年的其他新进展]
Rev Med Suisse. 2020 Sep 2;16(704):1544-1547.
7
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD.一个缩写中的一个字母变化：从非酒精性脂肪性肝病 (NAFLD) 到代谢相关性脂肪性肝病 (MAFLD) 的信号、原因、承诺、挑战和前进步骤。
Expert Rev Gastroenterol Hepatol. 2021 Apr;15(4):345-352. doi: 10.1080/17474124.2021.1860019. Epub 2020 Dec 9.
8
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years.从非酒精性脂肪性肝病（NAFLD）到代谢相关脂肪性肝病（MAFLD）：跨越40年的历程
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):695-696. doi: 10.1016/j.dsx.2020.05.019. Epub 2020 May 13.
9
Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.将脂肪性肝病从非酒精性脂肪性肝病重新定义为代谢功能障碍相关脂肪性肝病提高了疾病认知度：墨西哥的经验。
J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.
10
Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?脂肪性肝病：它是非酒精性脂肪性肝病还是肥胖相关性脂肪性肝病？
Eur J Gastroenterol Hepatol. 2019 Jan;31(1):143. doi: 10.1097/MEG.0000000000001279.

引用本文的文献

1
Association between total body muscle percentage and prevalence of non-alcoholic fatty liver disease in Korean adults findings from an 18-year follow-up: a prospective cohort study.韩国成年人全身肌肉百分比与非酒精性脂肪性肝病患病率的关联：一项18年随访的前瞻性队列研究结果
J Yeungnam Med Sci. 2023 Nov;40(Suppl):S47-S55. doi: 10.12701/jyms.2023.00605. Epub 2023 Aug 29.
2
Metabolic Disorders in Menopause.更年期的代谢紊乱
Metabolites. 2022 Oct 8;12(10):954. doi: 10.3390/metabo12100954.
3
Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice.
饮食诱导的遗传多样性合作杂交小鼠非酒精性脂肪性肝病肝酯化脂肪酸组成的脂质组学分析。
J Nutr Biochem. 2022 Nov;109:109108. doi: 10.1016/j.jnutbio.2022.109108. Epub 2022 Jul 17.
4
MAFLD and CKD: An Updated Narrative Review.MAFLD 和 CKD：更新的叙述性综述。
Int J Mol Sci. 2022 Jun 23;23(13):7007. doi: 10.3390/ijms23137007.
5
Regulation of Lipid Metabolism by Lamin in Mutation-Related Diseases.核纤层蛋白在突变相关疾病中对脂质代谢的调控
Front Pharmacol. 2022 Feb 25;13:820857. doi: 10.3389/fphar.2022.820857. eCollection 2022.
6
Recent Developments in NAFLD.非酒精性脂肪性肝病的最新进展。
Int J Mol Sci. 2022 Mar 7;23(5):2882. doi: 10.3390/ijms23052882.
7
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes.2型糖尿病患者的非酒精性脂肪性肝病与大血管和微血管并发症风险
J Clin Med. 2022 Feb 12;11(4):968. doi: 10.3390/jcm11040968.
8
Biliary Epithelial Senescence in Liver Disease: There Will Be SASP.肝病中的胆管上皮细胞衰老：将会出现衰老相关分泌表型。
Front Mol Biosci. 2021 Dec 21;8:803098. doi: 10.3389/fmolb.2021.803098. eCollection 2021.
9
Treating the Metabolic Syndrome by Fecal Transplantation-Current Status.通过粪便移植治疗代谢综合征——现状
Biology (Basel). 2021 May 20;10(5):447. doi: 10.3390/biology10050447.
10
Treatments for NAFLD: State of Art.非酒精性脂肪性肝病的治疗：现状
Int J Mol Sci. 2021 Feb 26;22(5):2350. doi: 10.3390/ijms22052350.